** Shares of medical equipment maker West Pharmaceuticals WST.N rise 1.3% to $221 premarket
** Company raised its annual profit forecast to $6.15 to $6.35 a share, up from a previous range of $6 to $6.20 a share
** This profit raise comes despite the company anticipating a $20 million to $25 million hit from U.S. President Donald Trump's tariffs
** Analysts on average were expecting annual profit of $6.14/share, as per data compiled by LSEG
** WST posts Q1 revenue of $698 million, beating Wall Street estimate of $685.84 million
** Co reports Q1 adj. profit of $1.45/share, vs analysts' estimate of $1.23/share
** As of last close, WST stock down 33.4% YTD
(Reporting by Padmanabhan Ananthan)
((Padmanabhan.Ananthan@thomsonreuters.com))
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。